From ocular oncology to tackling neglected diseases, our 2020 Power Listers are making their mark on ophthalmology – and beyond.
Large-scale analysis of clinical trial data involves numerous challenges and significant manpower. Can deep learning facilitate the process?
Combining genetic testing with AI and machine learning offers virtually unlimited opportunities in disease detection, management, and treatment
Sitting Down With… Tim Clover, CEO of Rayner
The ARTEVO® 800 from ZEISS: a paradigm shift in ophthalmic visualization
EyeMD EMR’s newest release harnesses fog computing architecture to deliver a system without compromise
Michael D. Abramoff,
Four AI and deep learning gurus discuss the use of these advanced technologies in eye care – and predict where they may take us next
Electrical stimulation of neural responses can significantly improve outcomes for retinitis pigmentosa patients
When even the world’s wealthiest economies struggle to fund gene therapies, we have a problem that demands disruptive solutions
Aflibercept’s newly approved administration regime permits a reduction in intravitreal injection frequency
Ahead of the Ophthalmology Innovation Summit 2019 at AAO, we reach out to a panel of experts to uncover market trends
Send me the latest from The Ophthalmologist.
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.